Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07802366
NA

Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria

Sponsor: metaX Institut fuer Diatetik GmbH

View on ClinicalTrials.gov

Summary

XPhePiccosMR is a prospective, single-arm, open label, observational study that aims to evaluate the acceptability and tolerability of XPhe Piccos, a slow-release, phenylalanine-free protein substitute in the form of tiny tablets, for use in the dietary management of phenylketonuria (PKU) in children aged three years and older.

Official title: XPhe Piccos - Acceptability and Tolerance Market Research

Key Details

Gender

All

Age Range

3 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-10-01

Completion Date

2027-08-01

Last Updated

2026-09-03

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Slow release, phenylalanine-free protein substitute tablets

Subjects who currently take a concentrated second stage phenylalanine-free protein substitute will be recruited. Subjects will take the study product for 7 days. Subjects will replace some or all of their usual protein substitute with the new product. The amount of study product prescribed will be calculated to provide the same amount of protein as their usual protein substitute.

Locations (1)

Birmingham Children´s Hospital

Birmingham, England, United Kingdom